enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
6.96
-0.24 (-3.33%)
Apr 28, 2026, 4:00 PM EDT - Market closed
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $466.25 million as of April 29, 2026. Its market cap has increased by 128.65% in one year.
Market Cap
466.25M
Enterprise Value
223.76M
1-Year Change
128.65%
Ranking
Category
Stock Price
$6.96
Market Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has increased from $155.91M to $466.25M, an increase of 199.05%. That is a compound annual growth rate of 29.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 482.32M | -20.26% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 482.95M |
| Verastem | 479.62M |
| ADC Therapeutics | 479.50M |
| Contineum Therapeutics | 467.26M |
| Ovid Therapeutics | 467.20M |
| Entrada Therapeutics | 464.04M |
| Eikon Therapeutics | 463.43M |
| Larimar Therapeutics | 457.08M |